Sarip, Haiba A.

HRN: 22 79 29  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/09/2025
06/16/2025
IV
4.5g
Q8h
Infected Wound Lumbosacral Area Bilateral
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: